186 related articles for article (PubMed ID: 14599865)
1. P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma.
Cho NH; Kim YB; Park TK; Kim GE; Park K; Song KJ
Gynecol Oncol; 2003 Nov; 91(2):346-53. PubMed ID: 14599865
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.
Gaffney DK; Haslam D; Tsodikov A; Hammond E; Seaman J; Holden J; Lee RJ; Zempolich K; Dodson M
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):922-8. PubMed ID: 12829126
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of p53 and Bcl-2 expression as prognostic markers in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy.
Jain D; Srinivasan R; Patel FD; Kumari Gupta S
Gynecol Oncol; 2003 Jan; 88(1):22-8. PubMed ID: 12504622
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of human papillomavirus (HPV) status and expression of selected markers (HER2/neu, EGFR, VEGF, CD34, p63, p53 and Ki67/MIB-1) on outcome after (chemo-) radiotherapy in patients with squamous cell carcinoma of uterine cervix.
Vosmik M; Laco J; Sirak I; Beranek M; Hovorkova E; Vosmikova H; Drastikova M; Hodek M; Zoul Z; Odrazka K; Petera J
Pathol Oncol Res; 2014 Jan; 20(1):131-7. PubMed ID: 23913252
[TBL] [Abstract][Full Text] [Related]
6. Synchronous coexpression of epidermal growth factor receptor and cyclooxygenase-2 in carcinomas of the uterine cervix: a potential predictor of poor survival.
Kim GE; Kim YB; Cho NH; Chung HC; Pyo HR; Lee JD; Park TK; Koom WS; Chun M; Suh CO
Clin Cancer Res; 2004 Feb; 10(4):1366-74. PubMed ID: 14977838
[TBL] [Abstract][Full Text] [Related]
7. Re: "P63 and EGFR as prognostic predictors in stage IIB radiation-treated cervical squamous cell carcinoma".
Van de Putte G; Vach W
Gynecol Oncol; 2005 Aug; 98(2):335-6. PubMed ID: 16039312
[No Abstract] [Full Text] [Related]
8. Tumor hypoxia, p53, and prognosis in cervical cancers.
Haensgen G; Krause U; Becker A; Stadler P; Lautenschlaeger C; Wohlrab W; Rath FW; Molls M; Dunst J
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):865-72. PubMed ID: 11429213
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathology significance of p53 and p63 expression in Indonesian cervical squamous cell carcinomas.
Romus I; Triningsih FE; Mangunsudirdjo S; Harijadi A
Asian Pac J Cancer Prev; 2013; 14(12):7737-41. PubMed ID: 24460361
[TBL] [Abstract][Full Text] [Related]
10. Expression of the p53 homologue p63 in early cervical neoplasia.
Quade BJ; Yang A; Wang Y; Sun D; Park J; Sheets EE; Cviko A; Federschneider JM; Peters R; McKeon FD; Crum CP
Gynecol Oncol; 2001 Jan; 80(1):24-9. PubMed ID: 11136565
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of epidermal growth factor receptor signaling decreases p63 expression in head and neck squamous carcinoma cells.
Matheny KE; Barbieri CE; Sniezek JC; Arteaga CL; Pietenpol JA
Laryngoscope; 2003 Jun; 113(6):936-9. PubMed ID: 12782800
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy.
Pyo H; Kim YB; Cho NH; Suh CO; Park TK; Yun YS; Kim GE
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):725-32. PubMed ID: 15936552
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
Zhang MQ; Liu SP; Wang XE
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
16. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
[TBL] [Abstract][Full Text] [Related]
17. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
Ma R; Zhang H; Zou L; Qu Y
Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
[TBL] [Abstract][Full Text] [Related]
18. Mutation and transcription analyses of the p63 gene in cervical carcinoma.
Nishi H; Isaka K; Sagawa Y; Usuda S; Fujito A; Ito H; Senoo M; Kato H; Takayama M
Int J Oncol; 1999 Dec; 15(6):1149-53. PubMed ID: 10568821
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of p63 expression in lung cancer by use of complementary DNA and tissue microarray].
Yu YW; Garber ME; Schlüns K; Pacyna-Gengelbach M; Petersen I
Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):324-7. PubMed ID: 15363316
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of p63 is associated with radiation resistance and prognosis in oral squamous cell carcinoma.
Moergel M; Abt E; Stockinger M; Kunkel M
Oral Oncol; 2010 Sep; 46(9):667-71. PubMed ID: 20656547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]